Qualcomm, Apple Renew Global Patent License Agreement
By Connor Hart
Qualcomm renewed its global patent license agreement with Apple, effective April 1, 2027.
The terms and duration of the pact weren't disclosed.
The partnership between Qualcomm and Apple was shaped by a 2019 settlement, which ended a long-brewing legal battle over how royalties are collected on innovations in smartphone technology.
With the settlement, the companies said in April 2019 that they had reached a six-year license agreement and a multiyear deal for Qualcomm to supply Apple with modem chips. Now, that agreement has been extended.
"We are pleased to extend the Apple license agreement," John Han, general manager of Qualcomm Technology Licensing, said Thursday.
Still, Apple in recent years has sought to become less reliant on Qualcomm, which makes smartphone processors. Apple last year launched the iPhone 16e, an update to a budget-friendly version of its flagship device that featured the company's first in-house cellular chip.
The device marked a long-awaited step in Apple's efforts to make more of its own technology, as well as to wean itself from having to pay billions annually to Qualcomm, which receives licensing revenue from handset makers based on the number of units shipped.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
September 24, 2026 08:38 ET (12:38 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States